Allele loss on chromosome 11q and microsatellite instability in malignant melanoma

European Journal of Cancer Part A

Volumn 32, Issue 10, 1996, Pages 1797-1802

  Tomlinson, I P M ^a   Beck, N E ^a   Bodmer, W F ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

11q; HNPCC; LOH; Melanoma; Microsatellite instability

Indexed keywords

ARTICLE; CHROMOSOME 11Q; CLINICAL ARTICLE; CONTROLLED STUDY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MELANOMA; MICROCHROMOSOME; PRIORITY JOURNAL;

EID: 0030249881     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00198-0     Document Type: Article

References (31)

1. 1. Fountain JW, Karayiorgou M, Ernstoff MS, et al. Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci USA 1992, 89, 10557-10561.
2. 2. Puig S, Ruiz A, Lazaro C, et al. Chromosome 9p deletions in cutaneous malignant melanoma tumors - the minimal deleted region involves markers outside the p16 (cdkn2) gene. Am J Hum Genet 1995, 57, 395-402.
3. 3. Isshiki K, Elder DE, Guerry D, Linnenbach AJ. Chromosome 10 allelic loss in malignant melanoma. Genes Chrom Cancer 1993, 8, 178-184.
4. 4. Millikin D, Meese E, Vogelstein B, Witkowski C, Trent J. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res 1991, 51, 5440-5453.
5. 5. Tomlinson IPM, Gammack AJ, Stickland JE, et al. Loss of heterozygosity in malignant melanoma at loci on chromosomes 11 and 17 implicated in the pathogenesis of other cancers. Genes Chrom Cancer 1993, 7, 169-172.
6. 6. Walker GJ, Palmer JM, Walters MK, Hayward NK. A genetic model of melanoma tumorigenesis based on allelic losses. Genes Chrom Cancer 1995, 12, 134-141.
7. 7. Healy E, Rehman I, Angus B, Rees JL. Loss of heterozygosity in sporadic cutaneous melanoma. Genes Chrom Cancer 1995, 12, 152-156.
8. 8. Herbst RA, Larson A, Weiss J, Cavanee WK, Hampton GM, Srden KC. A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma. Cancer Res 1995, 55, 2494-2496.
9. 9. Cowan JM, Francke U. Cytogenetic analysis in melanoma and naevi. Cancer Treat Res 1991, 54, 3-16.
10. 10. Kopf I, Stierner U, Islam Q, Delle U, Kindblom LG, Martinsson T. Characterisation of four melanoma cell lines with electron microscopy, immunocytochemistry, cytogenetics, flow cytometry, and southern analysis. Cancer Genet Cytogenet 1992, 62, 111-123.
11. 11. Morse HG, Gonzalez R, Moore GE, Robinson WA. Preferential chromosome 11q and/or chromosome 17q aberrations in short-term cultures of metastatic melanoma in resections from human brain. Cancer Genet Cytogenet 1992, 64, 118-126.
12. 12. Thompson FH, Emerson J, Olson S, et al. Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes. Cancer Genet Cytogenet 1995, 83, 93-104.
13. 13. Stickland JE, Tomlinson IPM, Lee ASG, Evans MF, McGee JO'D. Allelic loss on chromosome 11q is a frequent event in breast cancer. Br J Cancer 1992, 66, (Suppl. xvii), 3.
14. 14. Hampton GM, Winqvist R, Mannermaa A, et al. Loss of heterozygosity in human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res 1994, 54, 4586-4589.
15. 15. Carter SL, Negrini M, Baffa R, et al. Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res 1994, 54, 6270-6274.
16. 16. Tomlinson IPM, Stickland JE, Lee AS-G, et al. Frequent loss of heterozygosity on chromosome 11q in breast cancer. J Clin Pathol 1995, 48, 424-428.
17. 17. Hampton GM, Penny LA, Baergen RN, et al. Loss of heterozygosity in cervical carcinoma: sub-chromosomal location of a putative tumour suppressor gene at 11q22-q24. Proc Natl Acad Sci USA 1994, 91, 6953-6957.
18. 18. Bethwaite PB, Koreth J, Herrington CS, McGee JO'D. Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma. Br J Cancer 1995, 71, 814-818.
19. 19. Foulkes WD, Campbell IG, Stamp GWH, Trowsdale J. Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer. Br J Cancer 1993, 67, 268-273.
20. 20. Quinn AG, Healy E, Rehman I, Sikkink S, Rees JL. Microsatellite instability in human non-melanoma and melanoma skin cancer. J Invest Derm 1995, 104, 309-312.
21. 21. Gyapay G, Morissette J, Vignal A, et al. The 1993-94 Genethon human genetic-linkage map. Nature Genet 1994, 7, 246-339.
22. 22. Warnich L, Groenewald I, Theart L, Relief AE. Highly informative dinucleotide repeat polymorphism at the D11S29 locus on chromosome 11q23. Hum Genet 1992, 89, 357-359.
23. 23. Lothe RA, Peltomaki P, Meling GI, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993, 53, 5849-5852.
24. 24. Kamb A, Shattuckeidens D, Eeles R, et al. Analysis of the p16 gene (cdkn2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 1994, 8, 22-26.
25. 25. Hussussian CJ, Struewing JP, Goldstein AM, et al. Germline p16 mutations in familial melanoma. Nature Genet 1994, 8, 15-21.
26. 26. Gruis NA, Vandervelden PA, Sandkuijl LA, et al. Homozygotes for cdkn2 (p 16) germline mutation in Dutch familial melanoma kindreds. Nature Genet 1995, 10, 351-353.
27. 27. Ranade K, Hussussian CJ, Sikorski RS, et al. Mutations associated with familial melanoma impair p16(ink4) function. Nature Genet 1995, 10, 114-116.
28. 28. Liu Q, Neuhausen S, McClure M, et al. Cdkn2 (mts1) tumor-suppressor gene-mutations in human tumor-cell lines. Oncogene 1995, 10, 1061-1067.
29. 29. Dracopoli NC, Harnett P, Bale SJ, et al. Loss of alleles from the distal short arm of chromosome-1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 1989, 86, 4614-4618.
30. 30. Hamilton SR. Molecular genetics of colorectal carcinoma. Cancer 1992, 70, 1216-1221.
31. 31. Rodabaugh KJ, Blanchard G, Welch WR, Bell DA, Berkowitz RS, Mok SC. Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors. Cancer Res 1995, 55, 2169-2172.